Ридапт
(Мидостариум)
(25 mg)
(28)
(Таб)
Rydapt 25 mg 28 soft capsules, generic, India
In Stock
Midostaurin (as Rydapt) is a multi-target kinase inhibitor for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3. It was initially characterized as a potential broad-spectrum antineoplastic agent active against a variety of solid and hematopoietic tumors.4 It was approved on April 28, 2017, and has been shown to improve overall survival in patients with AML as adjuvant therapy along with chemotherapy agents.
-
Commercial name:Ридапт
-
Сhemical name:Мидостариум
-
Dosage:25 mg
-
Quantity:28
-
Release form:Таб
-
Виробник:India
No reviews yet